A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence in the country, health experts warn.
The vaccine has been out of stock for over a month, with some counties facing limited supply while others have complete stock out.
Prof.
Ruth Nduati, a Paediatrician and Researcher, emphasises the critical role of BCG vaccine in protecting newborns.
